107 filings
EFFECT
BIAF
BioAffinity Technologies Inc
17 Apr 24
Notice of effectiveness
12:15am
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
ARS
2023 FY
BIAF
BioAffinity Technologies Inc
15 Apr 24
Annual report to shareholders
6:32am
DEFA14A
BIAF
BioAffinity Technologies Inc
15 Apr 24
Additional proxy soliciting materials
6:17am
DEF 14A
BIAF
BioAffinity Technologies Inc
Definitive proxy
15 Apr 24
6:15am
EFFECT
nk95y9
8 Apr 24
Notice of effectiveness
12:15am
POS AM
7q9nc6hch
5 Apr 24
Prospectus update (post-effective amendment)
6:10am
POS AM
lm012cik06kj5
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
vl2st lpof2uv
1 Apr 24
Results of Operations and Financial Condition
4:00pm
D
55jrkwvef
20 Mar 24
$2.62 mm in equity / options / securities to be acquired, sold $2.62 mm, 3 investors
2:24pm
8-K
hbogcxme29wp 35uza5
13 Mar 24
Other Events
4:08pm
8-K
gb5vgf m01j
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
cf8 vtovc4
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
450dwkhi1j4lpz
7 Mar 24
Prospectus supplement for primary offering
9:57pm
8-K
7viws5cls63xn4r4v1
5 Mar 24
Increasing physician interest, newly approved reimbursement code driving growth
5:26pm
8-K
0zcp d9ku6y
31 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
acygb8mlhpxg
5 Dec 23
Departure of Directors or Certain Officers
8:45am